Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1995 Oct;86(2):219–223.

Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.

B D Brondz 1, D B Kazansky 1, A D Chernyshova 1, V S Ivanov 1
PMCID: PMC1383998  PMID: 7490121

Abstract

Six individual peptides of the major histocompatibility complex (MHC) class I molecule H-2Kb were synthesized. Intravenous injection of peptide 6 into mice prolonged the survival of Kb (BL/6 or B10.MBR) skin grafts on allogeneic R101 and B10.AKM mice, respectively. This was specific, as control skin grafts from Kk (B10.BR) or Kd (DBA/2) donors, respectively, were rejected at the same time in both control and peptide-treated mice. The optimal doses for peptide 6, which is from the alpha 2 domain, were defined. The test system was the inhibition of proliferation in vitro of naive lymph node cells by syngeneic mitomycin c-treated spleen cells from R101 mice preimmunized with irradiated stimulator splenocytes of Kb (BL/6) origin. Down-regulation was specific, as proliferation in response to third-party allogeneic stimulator Kk (B10.BR) splenocytes was not inhibited. Of the six peptides of H-2Kb tested, potent down-regulatory cells were induced by peptides 2 (alpha 1 domain) and 5 and 6 (alpha 2 domain). The greatest down-regulatory activity was obtained by giving peptide 2 to mice that had already been immunized against H-2Kb by injecting EL4 cells. Under the same conditions, injecting peptide 2 did not induce any cytotoxic T cells. In contrast, specific cytotoxic lymphocytes (CTL) were induced when cells from primed mice were incubated for 4 days with heated stimulator cells from BL/6 mice. The data suggest that peptides from MHC class I molecules activate precursors of down-regulatory T cells, but not of CTL, and this may explain their ability to prolong skin allograft survival.

Full text

PDF
219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen H., Wraith D., Pala P., Askonas B., Flavell R. A. Domain interactions of H-2 class I antigens alter cytotoxic T-cell recognition sites. Nature. 1984 May 17;309(5965):279–281. doi: 10.1038/309279a0. [DOI] [PubMed] [Google Scholar]
  2. Asherson G. L., Colizzi V., Zembala M. An overview of T-suppressor cell circuits. Annu Rev Immunol. 1986;4:37–68. doi: 10.1146/annurev.iy.04.040186.000345. [DOI] [PubMed] [Google Scholar]
  3. Bloom B. R., Salgame P., Diamond B. Revisiting and revising suppressor T cells. Immunol Today. 1992 Apr;13(4):131–136. doi: 10.1016/0167-5699(92)90110-S. [DOI] [PubMed] [Google Scholar]
  4. Bluestone J. A., Foo M., Allen H., Segal D., Flavell R. A. Allospecific cytolytic T lymphocytes recognize conformational determinants on hybrid mouse transplantation antigens. J Exp Med. 1985 Jul 1;162(1):268–281. doi: 10.1084/jem.162.1.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brondz B. D., Anfalova T. V., Pavlova L. S., Pankratova E. V., Kojich A. G., Moshnikov S. A. Utilization of the MHC class I (H-2Kb) purified molecule and its synthetic peptides for inhibition of Kb-specific suppressor T cells and their induction in vivo by the MHC peptides. Scand J Immunol. 1993 Jun;37(6):627–633. doi: 10.1111/j.1365-3083.1993.tb01674.x. [DOI] [PubMed] [Google Scholar]
  6. Brondz B. D., Karaulov A. V., Abronina I. F., Blandova Z. K. Biological immunological and genetic characterization of specific suppressor T cells and their receptors immune to antigens of the H-2 complex. Clonal structure, narrow specificity of receptors and genetic restriction of specific T-suppressor function. Mol Immunol. 1980 Jul;17(7):833–849. doi: 10.1016/0161-5890(80)90032-2. [DOI] [PubMed] [Google Scholar]
  7. Brondz B. D., Osipova T. V., Aptikaeva G. F., Kronin V. V. Special differentiation requirements of original and enriched secondary cytotoxic T lymphocyte precursors (pCTL-2 memory cell) specific for the class I histocompatibility molecule. Immunol Lett. 1990 Sep;25(4):319–324. doi: 10.1016/0165-2478(90)90202-2. [DOI] [PubMed] [Google Scholar]
  8. Del Prete G., De Carli M., Almerigogna F., Giudizi M. G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol. 1993 Jan 15;150(2):353–360. [PubMed] [Google Scholar]
  9. Dorf M. E., Kuchroo V. K., Collins M. Suppressor T cells: some answers but more questions. Immunol Today. 1992 Jul;13(7):241–243. doi: 10.1016/0167-5699(92)90002-O. [DOI] [PubMed] [Google Scholar]
  10. Drizlikh G. I., Andreyev A. V., Kotomina I. P., Brondz B. D. Quantitative estimation of cytotoxic activity of immune lymphocytes using 51Cr-labelled peritoneal macrophages as target cells. J Immunol Methods. 1975 Oct;8(4):383–393. doi: 10.1016/0022-1759(75)90060-5. [DOI] [PubMed] [Google Scholar]
  11. Engelhard V. H. Structure of peptides associated with MHC class I molecules. Curr Opin Immunol. 1994 Feb;6(1):13–23. doi: 10.1016/0952-7915(94)90028-0. [DOI] [PubMed] [Google Scholar]
  12. Fangmann J., Dalchau R., Fabre J. W. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med. 1992 Jun 1;175(6):1521–1529. doi: 10.1084/jem.175.6.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hall B. M. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med. 1985 Jan 1;161(1):123–133. doi: 10.1084/jem.161.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hori S., Sato S., Kitagawa S., Azuma T., Kokudo S., Hamaoka T., Fujiwara H. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. J Immunol. 1989 Sep 1;143(5):1447–1452. [PubMed] [Google Scholar]
  15. Hutchings P. R., Cooke A., Dawe K., Waldmann H., Roitt I. M. Active suppression induced by anti-CD4. Eur J Immunol. 1993 Apr;23(4):965–968. doi: 10.1002/eji.1830230431. [DOI] [PubMed] [Google Scholar]
  16. Müllbacher A., Hill A. B., Blanden R. V., Cowden W. B., King N. J., Hla R. T. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J Immunol. 1991 Sep 15;147(6):1765–1772. [PubMed] [Google Scholar]
  17. Nisco S., Vriens P., Hoyt G., Lyu S. C., Farfan F., Pouletty P., Krensky A. M., Clayberger C. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J Immunol. 1994 Apr 15;152(8):3786–3792. [PubMed] [Google Scholar]
  18. Okazaki H., Maki T., Wood M. L., Jones S., Monaco A. P. Prolongation of skin allograft survival in H-2 K and I region-incompatible mice by pretransplant blood transfusion. Transplantation. 1981 Aug;32(2):111–115. doi: 10.1097/00007890-198108000-00006. [DOI] [PubMed] [Google Scholar]
  19. Oluwole S. F., Chowdhury N. C., Jin M. X., Hardy M. A. Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides. Transplantation. 1993 Dec;56(6):1523–1527. doi: 10.1097/00007890-199312000-00046. [DOI] [PubMed] [Google Scholar]
  20. Qin S., Cobbold S. P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. "Infectious" transplantation tolerance. Science. 1993 Feb 12;259(5097):974–977. doi: 10.1126/science.8094901. [DOI] [PubMed] [Google Scholar]
  21. Rodrigues M. A., Hutchinson I. V., Morris P. J. Alloreactive T suppressor cells in the rat. I. Evidence of three distinct subsets of splenic suppressor T cells resistant to cyclosporine. Transplantation. 1989 May;47(5):847–852. doi: 10.1097/00007890-198905000-00020. [DOI] [PubMed] [Google Scholar]
  22. Sayegh M. H., Perico N., Gallon L., Imberti O., Hancock W. W., Remuzzi G., Carpenter C. B. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation. 1994 Jul 27;58(2):125–132. [PubMed] [Google Scholar]
  23. Stroynowski I., Lindahl K. F. Antigen presentation by non-classical class I molecules. Curr Opin Immunol. 1994 Feb;6(1):38–44. doi: 10.1016/0952-7915(94)90031-0. [DOI] [PubMed] [Google Scholar]
  24. Turka L. A., Tanaka K., Kupiec-Weglinski J. W., Milford E. L., Tilney N. L., Carpenter C. B. In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats. Transplantation. 1989 Feb;47(2):388–390. [PubMed] [Google Scholar]
  25. Zaitseva M. B., Brondz B. D. Mechanism of MHC class II restriction in the interaction between specific suppressor and responder T cells in a proliferative response: Ia interaction with a putative anti-self receptor, expressed on pre-activated responder cells. Immunology. 1990 Jul;70(3):372–378. [PMC free article] [PubMed] [Google Scholar]
  26. Zheng H., Boyer M., Fotedar A., Singh B., Green D. R. An antigen-specific helper T cell hybridoma produces an antigen-specific suppressor inducer molecule with identical antigenic fine specificity. Implications for the antigen recognition and function of helper and suppressor inducer T cells. J Immunol. 1988 Mar 1;140(5):1351–1358. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES